Previous | Next
212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247 of 999
laboratories, more facilities, more central staffing, and
so that the medical schools are really getting a good out out of
the research funds.
Consequently they're taking more students, too, aren't they?
No, that's not related to students. There are other bills
that to the number of students. There's support for
medical schools and amounts for students. But deans don't like
to go out, it's hard, to go out and raise money for their schools.
It's much easier to take a bigger cut out of medical research
than it is to go out and raise money, the deans are never
interested in new payoffs in how to keep people longer
and in good conditions. That's a detail that doesn't bother them
at all, As long as they don't have a deficit in their schools
they don't care what happens, It's really true, you know.
So we didn't have a very outstanding year as far as
appropriations went. Senator Hill did earmark I think a specific
amount of money -- I think it was three million dollars. Wait
a minute, I think it may have been -- well, maybe about million
dollars, for Parkinson's disease research centers, where the
new drug for Parkinsonism, L-DOPA, was to be tried. Now, this
was going ahead as of this fall, they were going to give the
money to the 20 centers to try L-DOPA on Parkinson's disease
victims, so that they'd get a better idea of how to use the drug
and what other diseases might be affected by the drug, on the
© 2006 Columbia University
Libraries | Oral History
Research Office | Rights and
Permissions | Help